[RNAZ] YoY Quarter Result on 31-Mar-2024 [#Q1]

Stock
[RNAZ] TransCode Therapeutics, Inc.
Announcement Date
15-May-2024
Financial Year
2024
Quarter
31-Mar-2024 [#Q1]
Profit Trend
QoQ- 18.62%
YoY- 30.86%
Quarter Report
RNAZ's Result
RNAZ's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 CAGR
Revenue 0 0 0 0 0 -
PBT -3,327 -4,817 -3,470 -4,485 -41 199.90%
Tax -179 -5 -7 3,983 -0 -
NP -3,327 -4,812 -3,463 -4,485 -41 199.90%
Tax Rate - - - - - -
Total Cost 3,327 4,812 3,463 4,485 41 199.90%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 CAGR
EPS -0.65 -267.34 -216.41 -278.07 -6.53 -43.80%
EPS Diluted -0.65 -267.34 -213.45 -278.07 -6.53 -43.80%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.